Secondary pharmaceuticals manufacturing.

J N, Burling; P V, Shah

Found an issue? Give us feedback

https://pubmed.ncbi....arrow_drop_down

https://pubmed.ncbi.nlm.nih.go...

Article . 1997

Data sources: Europe PubMed Central

Secondary pharmaceuticals manufacturing.

descriptionPublicationkeyboard_double_arrow_right Article 23 Jul 1997 English Journal:Occupational medicine (Philadelphia, Pa.), volume 12 (issn: 0885-114X,

Copyright policy )

Authors: J N, Burling; P V, Shah;

pmid: 9153051

Secondary pharmaceuticals manufacturing.

- Summary
- Subjects
- Metrics

Abstract

Drs. Burling and Shah examine the second part of the pharmaceuticals manufacturing process, in which formulations for drug delivery are determined. Several types of formulations and their potentials for occupational exposure are reviewed.

Keywords

Drug Industry, Administration, Topical, Chemistry, Pharmaceutical, Suppositories, Nonprescription Drugs, United States, Solutions, Drug Delivery Systems, Liposomes, Animals, Humans, Ethics, Medical, Infusions, Parenteral, Drug Packaging, Drug Labeling, Skin, Tablets

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	0
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average